The Influence of Mucosal Tissue Thickness on Soft and Hard Tissue Changes Around Implants. A Randomized Controlled Clinical Study
试验速览
- 阶段
- 不适用
- 入组人数
- 140
- 试验地点
- 1
- 主要终点
- Marginal bone loss around implant
研究概览
简要总结
Crestal bone and soft tissue stability around implants is an important issue in implant dentistry. Initial vertical mucosal tissue thickness was shown to be one of the factors having impact on bone stability. However, there is lack of data in the literature regarding the relationship between mucosal thickness and marginal bone loss around implants. Berglundh and Lindhe in an animal study reported that thin mucosal tissue causes significantly more crestal bone resorption around implants. In addition, clinical research regarding the effects of tissue thickness on bone and soft tissue stability around implants is lacking. The aim of this clinical study is to evaluate the influence of mucosal tissue thickness on soft and hard tissue changes around implants.
详细描述
The objectives of this clinical study are;
- to evaluate the influence of mucosal tissue thickness on periimplant soft and hard tissue changes.
- to evaluate whether acellular dermal matrix (ADM) derived allogenic membrane or subepithelial connective tissue grafts performed at implant placement could be effective in vertical soft tissue augmentation.
- to evaluate the influence of vertical soft tissue augmentation with acellular dermal matrix or subepithelial connective tissue grafts on soft and hard tissue changes around implants with platform switching after 1 year of loading.
Partially edentulous patients in the posterior lower jaw area requiring implant treatment will be recruited for this study. There will be four groups in the study with 35 patients in each group.
Inclusion criteria will be; (1) >18 years of age; (2) no medical contraindication for implant surgery; (3) missing teeth in the posterior mandibular area requiring two implants supported three unit bridge prosthetic restoration; (4) fully healed bone sites (at least 3 months after extraction) (5) minimum of 6mm bone width and 10 mm bone height above inferior alveolar canal; (6) healthy soft tissue; (7) minimum 2mm keratinized gingiva; (8) no bone augmentation procedures before and during implant placement. The patients will be excluded if they will not meet inclusion criteria and additionally have (1) poor oral hygiene; (2) uncontrolled periodontitis (3) smoking Ethical approval was taken from Cukurova University Ethical Committee and the patients will sign informed consent form before participating in the study. Cone beam computerized tomography will be taken from all patients in order to evaluate the future implant sites. Patients will be enrolled if they fulfill the inclusion criteria. Patients will be excluded if they will not meet inclusion criteria and additionally have exclusion criteria. Two implants per patient will be placed. The prosthetic restorations will be performed as three unit bridge with two supported implants. These two implants in the premolar and molar regions will be included into the study and evaluated independently.
One hour prior to surgery the patients will receive prophylactic dose of 1 g amoxicillin+clavulanic acid. All surgical procedures will be performed by two experienced surgeons under local anesthesia. A mid-crestal incision on the center of edentulous ridge will be performed, leaving at least width of 2 mm keratinized tissues buccally. Next, a full-thickness buccal flap will be raised, while lingual part will not be elevated to ensure direct visibility. Vertical thickness of soft tissues will be measured with 1.0 mm marked periodontal probe. The probe will be positioned in an upright position to the bone crest in the center of the future implant placement. After measurement, lingual flap will be raised to completely expose the implantation site. If vertical soft tissue thickness is 2 mm or less, tissues will be considered as thin. If soft tissue thickness is more than 2mm, tissues will be considered as thick. There will be four groups in the study.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Factorial
- 主要目的
- Screening
- 盲法
- Single (Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •>18 years of age
- •no medical contraindication for implant surgery
- •missing teeth in the posterior mandibular area requiring two implants supported three unit bridge prosthetic restoration
- •fully healed bone sites (at least 3 months after extraction)
- •minimum of 6mm bone width and 10 mm bone height above inferior alveolar canal
- •healthy soft tissue
- •minimum 2mm keratinized gingiva
- •no bone augmentation procedures before and during implant placement.
排除标准
- •The patients will be excluded if they will not meet inclusion criteria and additionally have
- •poor oral hygiene
- •uncontrolled periodontitis
研究组 & 干预措施
Thick mucosal tissue
Implants with platform switching (Astra Tech Implant System EV) will be placed and cover screws will be inserted.
干预措施: Dentsply Astra Tech Implant System EV (Device)
Thin mucosal tissue
Implants with platform switching (Astra Tech Implant System EV) will be placed and cover screws will be inserted.
干预措施: Dentsply Astra Tech Implant System EV (Device)
Thickened mucosa with connective tissue
Implants with platform switching (Astra Tech Implant System EV) will be placed and cover screws will be inserted. Soft tissue augmentation will be performed with sub epithelial connective tissue graft.
干预措施: Dentsply Astra Tech Implant System EV (Device)
Thickened mucosa with ADM
Implants with platform switching (Astra Tech Implant System EV) will be placed and cover screws will be inserted. Acellular dermal matrix, thick 1 x 4 cm will be used for vertical soft tissue augmentation.
干预措施: Dentsply Astra Tech Implant System EV (Device)
结局指标
主要结局
Marginal bone loss around implant
时间窗: The mean change in marginal bone loss from baseline marginal bone level at implant placement to 12 months of implant loading.
The measurements will be performed using Image J analysis software program (Image J version 1.44-National Institutes of Health, NIH) by an examiner who is unaware of the group assignment. The intra-examiner and inter-examiner agreement will be determined.
次要结局
- Soft tissue changes around implant(Periodontal indexes will be evaluated at 12 months after implant loading.)
- Soft tissue changes around implant(Periodontal indexes will be evaluated at 18 weeks after implant placement at prosthetic delivery.)
- Soft tissue changes around implant(Periodontal indexes will be evaluated at 6 months after implant loading)
研究者
M.Emre Benlidayi
Associate Professor
Cukurova University
